The Roads in Drug Discovery and Nanotechnology

About the Journal
The Roads in Drug Discovery and Nanotechnology is an international, peer-reviewed journal that publishes high-quality research at the intersection of pharmaceutical sciences and nanotechnology. The journal highlights innovative approaches, advanced technologies, and translational research that accelerate drug discovery and improve therapeutic outcomes.

Aims and Scope
The study published in The Roads in Drug Discovery and Nanotechnology aims to increase understanding of drug discovery and nanotechnology. Our outstanding international editorial team of experts evaluates submitted works, along with other members of the global scientific community who are experts in the relevant field. All papers with high scientific value are carefully assessed by the editors and then sent for further peer review.

The scope of the journal includes but is not limited to: Novel strategies and targets in drug discovery; nanotechnology-enabled drug delivery systems; nanomedicine and nano-formulations for diagnostics and therapy; computational methods, and machine learning in drug design; biomaterials, tissue engineering, and regenerative medicine applications; toxicology, pharmacokinetics, and safety evaluation of nanomedicines; translational and clinical studies of nano-based therapeutics.

Submitted papers with new and significant results, confirmed by updated and reliable methods, will be considered for publication. Papers are accepted in both animal and clinical experimentation. The journal also welcomes preliminary, explanatory, and concise small-scale results if they show the potential to advance and/or inform hypotheses or future drug and nanotechnology research. By fostering a multidisciplinary platform, the Drug Discovery and Nanotechnology journal seeks to connect researchers from pharmaceutical sciences, chemistry, biology, materials science, and clinical medicine, paving the way for innovative solutions in precision medicine and global health.

Article Types
The Roads in Drug Discovery and Nanotechnology publishes original research articles, review papers, methodological papers, brief research communications, and Special Issue contributions. Well-designed preliminary or small-scale studies may be considered when they are methodologically appropriate, clearly reported, and able to test hypotheses, guide future research, or inform drug discovery and nanotechnology practice.

Reasons to Publish in The Roads in Drug Discovery and Nanotechnology
•    A clear international profile in drug discovery and nanotechnology, and related interdisciplinary fields
•    A transparent editorial and peer-review process
•    Rigorous evaluation by editors and reviewers with relevant expertise
•    A user-friendly online submission and peer-review system for manuscript submission and tracking
•    An online publication that increases the visibility and accessibility of accepted articles
•    Full citability of published articles through DOI assignment
•    No submission fee and no page charges at the point of submission

Special Issues
The journal welcomes special Issues on timely and important topics within the scope of Drug Discovery and Nanotechnology. Special Issues are edited by Guest Editors appointed by the Editor-in-Chief. Researchers may also propose a special issue topic to the Editor-in-Chief. Proposals are evaluated by the Editorial Board, and the proposer is informed of the decision. Information on forthcoming and past special issues is provided in the relevant section of the journal homepage.

Readership
The readership comprises researchers in pharmaceutical sciences, chemistry, biology, materials science, and clinical medicine, paving the way for innovative solutions in precision medicine and global health sciences.

Abstracting and Indexing Information
Abstracting and indexing information will be updated as the journal is accepted by relevant abstracting and indexing services and databases.

Submission Information
Authors interested in submitting to the Drug Discovery and Nanotechnology should consult the journal’s Author Guidelines, which provide information on manuscript preparation, article structure, ethical requirements, references, tables, figures, and submission procedures. All submissions should be made through the journal’s online submission system.
Submission system: https://theroadsin.com/login

Open Access
Drug Discovery and Nanotechnology is published as an open-access journal, making articles available to readers without subscription barriers. This model supports the wide dissemination of research findings and helps ensure that carefully reviewed knowledge is accessible to researchers, practitioners, policy makers, and the wider public.

The publisher’s open-access policy defines the license and reuse conditions that apply to published articles. Any third-party images, figures, tables, or other materials included in articles may be subject to separate copyright or permission requirements.

Copyright and Reuse
Authors retain copyright of articles published in the Drug Discovery and Nanotechnology, unless otherwise stated in the journal’s official policy. Third-party materials remain subject to the rights of their original copyright holders. Reuse, distribution, and reproduction of published material are governed by the journal’s official open-access license and copyright policy. Authors are responsible for obtaining permission for any third-party material included in their manuscripts.

Article Processing Charges and Waivers
There is no submission fee or page charge at the time of submission. Information about Article Processing Charges (APCs), if applicable, and available waiver or discount options is provided through the publisher’s official Open Access and fee policies.

Kaplan SANEN Publishing may consider full or partial APC waivers for corresponding authors from low-income economies, resource-limited settings, or countries affected by war, natural disasters, economic collapse, or humanitarian emergencies, in accordance with the publisher’s official waiver policy. Authors who wish to request a waiver or discount are advised to do so at the time of submission. Each request is evaluated according to the publisher’s stated criteria.

Editorial Structure and Peer Review
Submitted manuscripts undergo technical and editorial screening before publication. This stage may include checks for format, completeness, reference style, text similarity, ethical statements, and basic compliance with the journal’s requirements. Manuscripts that do not meet the necessary requirements may be returned to the corresponding author for correction before editorial evaluation continues.

After the initial screening, suitable manuscripts are evaluated by the Editor-in-Chief and assigned to an appropriate Associate Editor or Section Editor. The Associate Editor oversees the editorial handling of the manuscript and may appoint a Review Editor to coordinate the peer-review process. The Review Editor invites at least two reviewers with relevant expertise.

The peer-review process includes an independent review phase, during which reviewers evaluate the manuscript according to objective scholarly criteria. Where appropriate, the process may proceed to an interactive review phase, in which authors respond to reviewer comments through the journal’s online system. The Review Editor and Associate Editor may guide this process to ensure that the revision remains constructive, rigorous, and fair.

After peer review and revision, the Review Editor evaluates the reviewers’ reports and the authors’ responses. The Associate Editor considers the full review record and makes an editorial recommendation or decision in accordance with the journal’s official workflow. The Editor-in-Chief retains oversight of the journal’s editorial standards and may intervene, when necessary, particularly in cases involving ethical concerns, scientific misconduct, or serious questions about the suitability of a manuscript.

Reviewer Confidentiality and Transparency
During the review process, reviewer independence and freedom of scholarly judgment are protected. Reviewer identities remain confidential during evaluation unless the journal’s official policy states otherwise. The decision to accept an article is based on the reviewers’ recommendations, the handling editor’s assessment, and the journal’s editorial policy. To ensure transparency and accountability in peer review, the names of the Associate Editor, Review Editor, and Reviewers are displayed in published articles. This supports transparency and accountability in the editorial process and recognizes the scholarly contribution of those involved in peer review.

Conflicts of Interest and Editorial Independence
Editors, Review Editors, and reviewers involved in manuscript evaluation do not receive any financial incentive linked to the acceptance of manuscripts. Editorial decisions must be based on scientific quality and methodological soundness.

Any recognition or acknowledgment offered to editors or reviewers must remain separate from the editorial decision and must not influence acceptance or rejection. This separation is essential for protecting editorial independence and maintaining trust in the review process.

Post-Publication Quality Control
The Roads publishing platform supports scholarly discussion and post-publication engagement. If serious concerns arise after publication, including ethical violations, integrity issues, or scientific misconduct, the publisher may initiate an evaluation in accordance with its correction and retraction procedures. When concerns are verified, appropriate action is taken in accordance with the journal’s policies and recognized standards of scholarly publishing.

Contact

Field Chief Editor/s

The Roads in Support
info@theroadsin.com